Cargando…

CRISPR-Cas systems: ushering in the new genome editing era

In recent years there has been great progress with the implementation and utilization of Clustered Regularly Interspaced Palindromic Repeats (CRISPR) and CRISPR-associated protein (Cas) systems in the world of genetic engineering. Many forms of CRISPR-Cas9 have been developed as genome editing tools...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez Rojo, Fernando, Nyman, Rikard Karl Martin, Johnson, Alexander Arthur Theodore, Navarro, Maria Pazos, Ryan, Megan Helen, Erskine, William, Kaur, Parwinder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067892/ https://www.ncbi.nlm.nih.gov/pubmed/29968520 http://dx.doi.org/10.1080/21655979.2018.1470720

Ejemplares similares

CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
por: Li, Ruiting, et al.
Publicado: (2022)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

mSphere of Influence: Ushering in the CRISPR Revolution to Toxoplasma Biology
por: Guerra, Alfredo J.
Publicado: (2019)

Optimization of genome editing through CRISPR-Cas9 engineering
por: Zhang, Jian-Hua, et al.
Publicado: (2016)

Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system
por: Zhang, Yuquan, et al.
Publicado: (2022)

Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity
por: DiEuliis, Diane, et al.
Publicado: (2017)

Expanding CRISPR repertoire using CjCas9 as a smaller editing tool
por: Francis, Christopher, et al.
Publicado: (2022)

Genomic Editing of Non-Coding RNA Genes with CRISPR/Cas9 Ushers in a Potential Novel Approach to Study and Treat Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2017)

CRISPR-Cas9 in hiPSCs: A new era in personalized treatment for Stargardt disease
por: Kuntam, Soujanya, et al.
Publicado: (2023)

Ushering in the era of penile transplantation
por: Rasper, Alison M., et al.
Publicado: (2017)

Ushering in the New Toxicology: Toxicogenomics and the Public Interest
por: Balbus, John M.
Publicado: (2005)

Living with Usher Syndrome: Patient and Physician Perspectives
por: Lønborg-Møller, Helene, et al.
Publicado: (2020)

CrisprGE: a central hub of CRISPR/Cas-based genome editing
por: Kaur, Karambir, et al.
Publicado: (2015)

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

CRISPR/Cas based gene editing: marking a new era in medical science
por: Prasad, Kirti, et al.
Publicado: (2021)

Genome editing of pseudorabies virus in the CRISPR/Cas9 era: a mini-review
por: Wang, Hai-Ming, et al.
Publicado: (2023)

Ushering in the era of tRNA medicines
por: Anastassiadis, Theonie, et al.
Publicado: (2023)

CRISPR/Cas9 editing of the MYO7A gene in rhesus macaque embryos to generate a primate model of Usher syndrome type 1B
por: Ryu, Junghyun, et al.
Publicado: (2022)

Genome editing before CRISPR: The gnostic bible
por: Kmiec, Eric B.
Publicado: (2023)

An Improved Protocol for Agrobacterium-Mediated Transformation in Subterranean Clover (Trifolium subterraneum L.)
por: Rojo, Fernando Perez, et al.
Publicado: (2021)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Genetic Diversity Linked to Haplotype Variation in the World Core Collection of Trifolium subterraneum for Boron Toxicity Tolerance Provides Valuable Markers for Pasture Breeding
por: Tahghighi, Hediyeh, et al.
Publicado: (2019)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Pathogen detection in the CRISPR–Cas era
por: Sashital, Dipali G.
Publicado: (2018)

Brookhaven ushers in a new bright era
Publicado: (2015)

The Era of Precision Medicine: Reshaping Usher Syndrome
por: Jung, Jinsei
Publicado: (2020)

Ethical implications of fighting malaria with CRISPR/Cas9
por: Patrão Neves, Maria, et al.
Publicado: (2017)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Genome Editing in Bacteria: CRISPR-Cas and Beyond
por: Arroyo-Olarte, Ruben D., et al.
Publicado: (2021)

CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
por: Monteys, Alex Mas, et al.
Publicado: (2017)

Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy
por: Schleidgen, Sebastian, et al.
Publicado: (2020)

CRISPR-mediated gene editing to rescue haploinsufficient obesity syndrome
por: Wang, Zhifeng, et al.
Publicado: (2019)

Commentary on “CRISPR/Cas9-mediated genome editing reveals 12 testis-enriched genes dispensable for male fertility in mice”
por: Houston, Brendan J
Publicado: (2021)

Meeting report: GARNet/OpenPlant CRISPR-Cas workshop
por: Parry, Geraint, et al.
Publicado: (2016)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
por: Dai, Wei-Jing, et al.
Publicado: (2016)

ge-CRISPR - An integrated pipeline for the prediction and analysis of sgRNAs genome editing efficiency for CRISPR/Cas system
por: Kaur, Karambir, et al.
Publicado: (2016)

Ushering in a new era of RNA-based therapies
por: DeLong, Robert
Publicado: (2021)

An optimized CRISPR/Cas9 approach for precise genome editing in neurons
por: Fang, Huaqiang, et al.
Publicado: (2021)

Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?
por: Ben-David, Uri
Publicado: (2013)

New CRISPR Tools to Correct Pathogenic Mutations in Usher Syndrome
por: Major, Lauren, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r2pc5d5p8ojcm1b7f4u208i402